atau cari berdasarkan hari
The Indonesian government decided to pause the use and distribution of the CTMAV547 batch of AstraZeneca vaccine.
BPOM has granted an emergency use authorization for COVID-19 vaccines Sinovac and Sinopharm produced by Chinese companies.
Sinopharm vaccines will be used for Indonesia's private vaccination program touted as the 'gotong royong' (mutual cooperation).
The BPOM has officially issued an emergency use authorization (EUA) for Sinopharm vaccines.
A meeting took place involving representatives from the Army, BPOM, and government which discussed the Nusantara Vaccine debacle.
Rector of Universitas Airlangga (Unair) Surabaya, Mohammad Nasih, expressed optimism that the Merah Putih vaccine will be ready for use in 2022.
The dendritic cell (DC)-based research is hoped to become the initial step to find a solution to improve one's immunity against COVID-19.
The Indonesian Military (TNI) has finally spoken up about the research of Nusantara vaccine development in Gatot Subroto Army Hospital (RSPAD).
Epidemiologist Windhu Purnomo said the Nusantara vaccine research team should have accepted the Food and Drug Monitoring Agency's (BPOM) decision.
A number of national figures declared their supports toward Indonesian Food and Drug Monitoring Agency (BPOM).
BPOM Head Penny Lukito said the mass production of homegrown COVID-19 vaccine dubbed the Merah Putih vaccine was hoped to commence in early 2022.
COVID-19 Task Force spokesman Wiku said the World Health Organization (WHO) will issue the emergency use listing (EUL) for the Sinovac vaccine in May.
BPOM Head Penny Lukito said the agency's assessment of the Nusantara Vaccine had complied with the applicable standards.
The Food and Drug Monitoring Agency (BPOM) said the interim data on the phase 2 clinical trial of the Nusantara vaccine was not sufficient.
BPOM inspection team report that Tempo obtained showed a number of oddities regarding the Nusantara vaccine's development.
The Nusantara vaccine has yet to fulfill good clinical practices, proof of concept, laboratory practice, and manufacturing set by the BPOM.
DPR Health Commission deputy head explains reasons for criticizing the BPOM over the development of the Nusantara vaccine.
The BPOM in today's House hearing announces 5 Covid-19 vaccines that are awaiting emergency use authorization (EUA) approval.
A new batch of Sinovac covid-19 vaccine raw materials - enough for 16 million doses - has landed at Soekarno-Hatta Airport.
BPOM head met with several DPR Commission Health members for talks of the Nusantara vaccine initiated by former Health Minister Terawan Agus Putranto.